GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
1R54 | Q9BZ11 | Crystal structure of the catalytic domain of human ADAM33 | |
1R55 | Q9BZ11 | Crystal structure of the catalytic domain of human ADAM 33 | |
7BH9 | Q9BYF1 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
7FDG | Q9BYF1 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
7KJ2 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | |
7NXC | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in complex with ACE2 | |
7EKH | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 | |
7SY0 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V83 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V84 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V85 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V86 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
7V86 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
7V87 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V87 | Q9BYF1 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V88 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V88 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V89 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V89 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
7V8A | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8A | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
7V8B | Q9BYF1 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7V8B | Q9BYF1 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7VX4 | Q9BYF1 | ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex | |
7VX5 | Q9BYF1 | ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex | |
7Y20 | Q9BYF1 | S-ECD (Omicron BA.3) in complex with two PD of ACE2 | |
7Y21 | Q9BYF1 | S-ECD (Omicron BA.5) in complex with PD of ACE2 | |
8WRH | Q9BYF1 | SARS-CoV-2 XBB.1.5.70 in complex with ACE2 | |
8WRL | Q9BYF1 | XBB.1.5 RBD in complex with ACE2 | |
8JYN | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) | |
8JYO | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) | |
8JYP | Q9BYF1 | Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 | |
7DDP | Q9BYF1 | Cryo-EM structure of human ACE2 and GX/P2V/2017 RBD | |
7DX9 | Q9BYF1 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound) | |
7EKE | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 | |
7SXZ | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) | |
7V81 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7V81 | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
7TEW | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
7WHH | Q9BYF1 | Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 | |
7WS8 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS9 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WSA | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7ZF7 | Q9BYF1 | SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 | |
7DX5 | Q9BYF1 | S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) | |
7FDI | Q9BYF1 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
7KJ4 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024